Actively Recruiting

Age: 20Years - 70Years
All Genders
Healthy Volunteers
NCT07141043

Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients

Led by Grigore T. Popa University of Medicine and Pharmacy · Updated on 2025-08-26

180

Participants Needed

1

Research Sites

114 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to integrate bone measurements (including bone turnover markers (BTM), bone mineral density (BMD) measurement, vertebral fracture assessment (VFA), trabecular bone score (TBS) ) commonly used in the general population for primary osteoporosis evaluation to enhance the assessment of CKD-MBD.

CONDITIONS

Official Title

Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients

Who Can Participate

Age: 20Years - 70Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients undergoing hemodialysis for at least 12 months, aged 20-70 years, who have signed informed consent
  • Kidney transplant recipients with successful transplant performed at least 12 months prior, aged 20-70 years, who have signed informed consent
  • Men and postmenopausal women diagnosed with primary osteopenia or osteoporosis, aged 50-70 years, who have signed informed consent
Not Eligible

You will not qualify if you...

  • Receiving active bone therapies other than calcium and vitamin D
  • Undergoing cancer treatment or recent history of malignancy
  • Cirrhosis
  • Recent major fractures
  • Having received transplants other than kidney
  • Secondary causes of osteoporosis other than CKD or transplant-related (including primary hyperparathyroidism, hyperthyroidism, congenital bone disorders, sarcoidosis, severe bone trauma, malignant tumors, inflammatory bowel disease, endogenous Cushing syndrome, anti-estrogen/anti-androgen therapy, and anorexia nervosa)
  • Pregnancy and breastfeeding
  • For kidney transplant recipients: return to dialysis or acute graft rejection
  • For general population group: diabetes mellitus and prolonged glucocorticoid therapy (over 7.5 mg Prednisone or equivalent for at least 3 months)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Medicine and Pharmacy "Grigore T. Popa"

Iași, Romania

Actively Recruiting

Loading map...

Research Team

N

Nada Akad, Dr.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here